Curated News
By: NewsRamp Editorial Staff
May 15, 2025
Intelligent Bio Solutions (NASDAQ: INBS) Reports Strong Commercial Growth in Fiscal Q3
TLDR
- Intelligent Bio Solutions (NASDAQ: INBS) expands rapidly, gaining 35 new accounts in fiscal Q3, positioning for entry into the multi-billion-dollar U.S. testing market.
- INBS uses its Intelligent Fingerprinting Drug Screening System for rapid, non-invasive testing, revolutionizing portable testing with fingerprint sweat analysis for drug use detection.
- INBS's technology offers hygienic and cost-effective drug testing solutions, benefiting safety-critical industries by providing quick results, potentially improving workplace safety and efficiency.
- INBS enters new sectors like luxury marine and waste management, expanding globally into 24 countries and partnering with 18 distributors, making strides in innovative drug testing solutions.
Impact - Why it Matters
This news matters as it showcases the success and expansion of Intelligent Bio Solutions, a company at the forefront of innovative drug testing technology. The company's growth signifies its potential to revolutionize portable testing and enhance workplace safety across various industries globally.
Summary
Intelligent Bio Solutions (NASDAQ: INBS) experienced significant commercial growth in fiscal Q3, adding 35 new accounts and expanding into various sectors and regions globally. The company now operates in 24 countries and partners with 18 distributors, setting the stage for entry into the lucrative U.S. testing market.
The Intelligent Fingerprinting Drug Screening System by INBS offers rapid, non-invasive drug testing solutions for workplace safety, with results available in under ten minutes. The system targets drugs like opiates, cocaine, methamphetamine, and cannabis, catering to industries such as construction, manufacturing, logistics, and drug treatment.
Source Statement
This curated news summary relied on this press release disributed by InvestorBrandNetwork (IBN). Read the source press release here, Intelligent Bio Solutions (NASDAQ: INBS) Reports Strong Commercial Growth in Fiscal Q3
